Not Medicare Enrolled

Christopher Logan, FNP-C

Nurse Practitioner - Primary Care · San Antonio, TX
11345 ALAMO RANCH PKWY STE 103, San Antonio, TX 78253
2109571693
Registered in NPPES since 2019
NPI: 1639710148 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Logan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Logan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Logan

Christopher Logan is a nurse practitioner - primary care in San Antonio, TX, with 6 years of NPI registration.

Between the years covered by Open Payments, Logan received a total of $6,218 from 31 pharmaceutical and/or device companies across 356 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Logan is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years of NPI registration $6,218 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,218
Total received (2021-2024)
Avg $1,554/year across 4 years
Top 3% in TX for nurse practitioner - primary care
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
356
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,755
2023
$1,954
2022
$1,308
2021
$1,201

Payments by company (2024)

ABBVIE INC.
$340
Lilly USA, LLC
$266
Novo Nordisk Inc
$263
PFIZER INC.
$245
AstraZeneca Pharmaceuticals LP
$226
Bayer Healthcare Pharmaceuticals Inc.
$134
SHIELD THERAPEUTICS INC
$92
Antares Pharma, Inc.
$70
Exact Sciences Corporation
$30
Inspire Medical Systems, Inc.
$30
GlaxoSmithKline, LLC.
$29
Azurity Pharmaceuticals, Inc.
$16
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 49.5% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,281
Novo Nordisk Inc
$850
AstraZeneca Pharmaceuticals LP
$708
Lilly USA, LLC
$673
Antares Pharma, Inc.
$325
Bayer Healthcare Pharmaceuticals Inc.
$303
PFIZER INC.
$301
GlaxoSmithKline, LLC.
$252
AbbVie Inc.
$223
Biohaven Pharmaceuticals, Inc.
$203
Takeda Pharmaceuticals U.S.A., Inc.
$135
Amarin Pharma Inc.
$128
SHIELD THERAPEUTICS INC
$92
Exact Sciences Corporation
$85
Janssen Pharmaceuticals, Inc
$78
Supernus Pharmaceuticals, Inc.
$63
Acerus Pharmaceuticals Corporation
$59
Clarus Therapeutics Inc.
$57
Azurity Pharmaceuticals, Inc.
$50
IDORSIA PHARMACEUTICALS US INC
$49
Esperion Therapeutics, Inc.
$48
Biohaven Pharmaceutical Holding Company Ltd.
$42
SANOFI-AVENTIS U.S. LLC
$37
ARBOR PHARMACEUTICALS, INC.
$33
Inspire Medical Systems, Inc.
$30
Kowa Pharmaceuticals America, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$23
Merck Sharp & Dohme Corporation
$19
Merck Sharp & Dohme LLC
$15
Arbor Pharmaceuticals, Inc.
$15
Shield Therapeutics Inc
$13
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · BREZTRI · COMIRNATY · Cologuard Collection Kit · EDARBI · EMGALITY · Edarbi · FARXIGA · FLUMIST QUADRIVALENT · GARDASIL 9 · INSPIRE · JARDIANCE · JATENZO · Kerendia · Livalo · MOUNJARO · NEXLETOL · NOCDURNA · NURTEC ODT · Natesto · Ozempic · PAXLOVID · QULIPTA · QUVIVIQ · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · Saxenda · Seglentis · TLANDO · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VRAYLAR · Vascepa · Wegovy · XARELTO · XYOSTED · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - primary care in San Antonio?
Compare nurse practitioner - primary cares in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse practitioner - primary cares in nearby ZIP areas
48
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
WESTOVER HILLS BAPTIST HOSPITAL
6.7 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Logan is a nurse practitioner - primary care.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Logan receive payments from pharmaceutical companies?
Yes. Logan received a total of $6,218 from 31 companies across 356 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Logan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Nurse Practitioner - Primary Cares in San Antonio
Browse nurse practitioner - primary cares in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Nurse Practitioner - Primary Cares in TX
Nurse practitioner - primary cares ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nurse Practitioner - Primary Cares in TX
Which TX nurse practitioner - primary cares receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →